Home/Filings/4/0001104659-22-061314
4//SEC Filing

Heier Jeffrey S. 4

Accession 0001104659-22-061314

CIK 0001393434other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:10 PM ET

Size

5.1 KB

Accession

0001104659-22-061314

Insider Transaction Report

Form 4
Period: 2022-05-12
Heier Jeffrey S.
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2022-05-12$3.05/sh+15,000$45,75039,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.015 to $3.05, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

OCULAR THERAPEUTIX, INC

CIK 0001393434

Entity typeother

Related Parties

1
  • filerCIK 0001653082

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:10 PM ET
Size
5.1 KB